Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2025 19:45 ET | Source: Nilo Therapeutics

Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO

NOVA YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- A Nilo Therapeutics, uma empresa de biotecnologia que utiliza circuitos neurais para restaurar a homeostase imunológica em doenças, foi lançada hoje com...
October 08, 2025 19:45 ET | Source: Nilo Therapeutics

Nilo Therapeutics 启动 1.01 亿美元 A 轮融资，以推进靶向免疫疾病神经回路的新型药物研发，并任命 Kim Seth 为首席执行官

纽约, Oct. 09, 2025 (GLOBE NEWSWIRE) -- 生物技术公司 Nilo Therapeutics 今日宣布完成 1.01 亿美元 A 轮融资。该公司致力于利用神经回路恢复疾病状态下的免疫稳态。此轮融资由 The Column Group (TCG)、DCVC Bio 和 Lux Capital 联合领投，Gates Foundation 与 Alexandria...
October 08, 2025 07:09 ET | Source: Nilo Therapeutics

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Nilo Therapeutics launches with $101 million Series A to target neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer